uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted November 01, 2017

Hemp Oil and Cannabidiol (CBD) Marketers Warned by FDA Over Claims

On November 1, 2017, the FDA announced it issued warning letters to four companies promoting products containing cannabidiol (CBD), a compound derived from cannabis (also known as marijuana), for the treatment of cancer, as well as other diseases, such as Alzheimer's disease. In the U.S., cannabidiol is not permitted to be sold as an ingredient in dietary supplements.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at